EXELON CORPORATION (EXC) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $18.86B (period ending 2008-12-31) to $24.26B (period ending 2025-12-31) — a 1.5% annual pace across 17 year(s) of filed history.
- Net margin compressed from 14.5% to 5.0% over that same span.
- Across 52 tracked quarters, the strongest was $9.89B (quarter ending 2021-03-31) and the weakest was $-26.0M (quarter ending 2018-06-30).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $-62.0M | 2018-12-31 | 10-K | 0001628280-19-001107 |
| Operating income | $5.15B | 2025-12-31 | 10-K | 0001109357-26-000018 |
| Net income | $1.17B | 2012-12-31 | 10-K | 0001193125-13-069749 |
| Diluted EPS | $1.74 | 2021-12-31 | 10-K | 0001109357-22-000039 |
| Total assets | $116.57B | 2025-12-31 | 10-K | 0001109357-26-000018 |
| Total liabilities | $87.77B | 2025-12-31 | 10-K | 0001109357-26-000018 |
| Cash & equivalents | $626.0M | 2025-12-31 | 10-K | 0001109357-26-000018 |
| Operating cash flow | $6.25B | 2025-12-31 | 10-K | 0001109357-26-000018 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $-5.0M | 2019-03-31 | 10-Q | 0001628280-19-005692 |
| Operating income | $1.60B | 2026-03-31 | 10-Q | 0001109357-26-000063 |
| Net income | $297.0M | 2012-09-30 | 10-Q | 0001193125-12-457787 |
| Diluted EPS | $0.90 | 2026-03-31 | 10-Q | 0001109357-26-000063 |
| Total assets | $117.55B | 2026-03-31 | 10-Q | 0001109357-26-000063 |
| Total liabilities | $88.23B | 2026-03-31 | 10-Q | 0001109357-26-000063 |
| Cash & equivalents | $713.0M | 2026-03-31 | 10-Q | 0001109357-26-000063 |
| Operating cash flow | $1.72B | 2026-03-31 | 10-Q | 0001109357-26-000063 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
Exelon Corporation’s business scale is substantial, with total assets exceeding $116 billion as of the most recent annual filing. The company’s revenue has shown a modest growth trajectory, increasing from $18.86 billion in 2008 to $24.26 billion in 2025, averaging a 1.5% annual growth rate over 17 years. However, the net margin has contracted significantly during this period, shrinking from 14.5% to 5.0%.
The multi-year trend indicates a business model that has expanded in absolute terms but has faced challenges in maintaining profitability, as evidenced by the declining net margin. The company’s operating income has grown substantially, reaching $5.15 billion in the most recent annual period. Meanwhile, diluted EPS has fluctuated, with a notable increase to $1.74 in 2021.
In the upcoming filings, investors should monitor the company’s ability to stabilize and improve its net margin, given the historical compression trend. Additionally, the consistency of operating income and cash flow generation will be crucial indicators of Exelon’s financial health and its capacity to manage liabilities exceeding $87 billion. The fluctuations in quarterly revenue, ranging from a peak of $9.89 billion to a low of -$26 million, suggest potential volatility that warrants close attention in future reports.
Source: SEC EDGAR company facts for CIK 0001109357 · filings index